HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brad S Kahl Selected Research

Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)

5/2022Long-term Outcomes With Ibrutinib Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma: A Pooled Analysis of 3 Clinical Trials With Nearly 10 Years of Follow-up.
1/2022Dose-finding study of ibrutinib and venetoclax in relapsed or refractory mantle cell lymphoma.
11/2021Multi-center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era.
9/2021Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival.
10/2020Initial and Consolidation Therapy for Younger Patients with Mantle Cell Lymphoma.
10/2019Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma.
1/2018VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study.
11/2017NR4A1 inhibition synergizes with ibrutinib in killing mantle cell lymphoma cells.
3/2017RB but not R-HCVAD is a feasible induction regimen prior to auto-HCT in frontline MCL: results of SWOG Study S1106.
1/2017Recent advances and future directions in mantle cell lymphoma research: report of the 2016 mantle cell lymphoma consortium workshop.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brad S Kahl Research Topics

Disease

36Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
05/2022 - 10/2005
32Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2021 - 01/2005
27Lymphoma (Lymphomas)
12/2022 - 09/2006
26Neoplasms (Cancer)
06/2022 - 03/2007
19Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2022 - 07/2005
18Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2022 - 12/2006
13Hodgkin Disease (Hodgkin's Disease)
10/2020 - 02/2013
9B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022 - 05/2010
7B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 01/2010
6Neutropenia
12/2021 - 03/2014
6Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2020 - 04/2012
5Genetic Translocation (Chromosomal Translocation)
01/2017 - 03/2010
4Leukemia
11/2020 - 01/2016
4Diarrhea
11/2018 - 03/2014
4Multiple Myeloma
01/2016 - 10/2006
3Disease Progression
12/2021 - 05/2007
3Thrombocytopenia (Thrombopenia)
12/2021 - 05/2014
3Nausea
01/2021 - 05/2014
3Exanthema (Rash)
09/2020 - 04/2011
3Burkitt Lymphoma (Burkitt's Lymphoma)
01/2020 - 03/2007
3Hematologic Neoplasms (Hematological Malignancy)
11/2018 - 03/2012
3Infections
08/2015 - 03/2007
2Febrile Neutropenia
06/2021 - 01/2020
2Fatigue
01/2021 - 05/2014
2T-Cell Lymphoma (Lymphoma, T Cell)
01/2019 - 07/2015
2Vomiting
04/2016 - 05/2014
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2016 - 03/2014
2Hemorrhage
08/2015 - 12/2003
2Lymphadenopathy
05/2014 - 01/2011
2Pneumonia (Pneumonitis)
05/2014 - 03/2014
2Fever (Fevers)
05/2014 - 03/2007
2Drug Hypersensitivity (Drug Allergy)
05/2014 - 04/2011
2Pathologic Complete Response
07/2011 - 01/2011
1Herpes Zoster
12/2022
1Septic Shock (Toxic Shock Syndrome)
12/2021
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
06/2021
1Edema (Dropsy)
01/2021

Drug/Important Bio-Agent (IBA)

44Rituximab (Mabthera)FDA Link
12/2022 - 03/2005
15Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2021 - 12/2006
15Prednisone (Sone)FDA LinkGeneric
01/2021 - 12/2006
15Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 12/2006
15Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 12/2006
13Bendamustine HydrochlorideFDA Link
12/2022 - 01/2010
7Biomarkers (Surrogate Marker)IBA
06/2022 - 01/2011
7Cyclin D1IBA
01/2017 - 03/2010
6Bortezomib (Velcade)FDA Link
01/2020 - 10/2006
6Etoposide (VP 16)FDA LinkGeneric
01/2020 - 10/2005
6idelalisibIBA
01/2017 - 03/2014
5ibrutinibIBA
05/2022 - 08/2013
5loncastuximab tesirineIBA
01/2022 - 11/2018
5Lenalidomide (CC 5013)FDA Link
12/2021 - 04/2016
5Biological ProductsIBA
12/2016 - 03/2010
4Alkylating AgentsIBA
04/2022 - 05/2010
4Agammaglobulinaemia Tyrosine KinaseIBA
01/2022 - 08/2013
4Dacarbazine (DIC)FDA LinkGeneric
01/2018 - 02/2013
4Bleomycin (Blenoxane)FDA LinkGeneric
01/2018 - 02/2013
4Vinblastine (Vinblastine Sulfate)FDA Link
01/2018 - 02/2013
3venetoclaxIBA
01/2022 - 01/2016
3Immunoconjugates (Immunoconjugate)IBA
01/2021 - 12/2019
3Transaminases (Aminotransferases)IBA
11/2018 - 03/2014
3Proteins (Proteins, Gene)FDA Link
01/2018 - 02/2013
3Proteasome InhibitorsIBA
10/2015 - 05/2008
3Pharmaceutical PreparationsIBA
03/2014 - 08/2010
2zanubrutinibIBA
01/2022 - 10/2020
2polatuzumab vedotinIBA
12/2021 - 12/2020
2YttriumIBA
06/2021 - 08/2014
2ibritumomab tiuxetan (Zevalin)FDA Link
06/2021 - 09/2012
2Brentuximab VedotinIBA
12/2020 - 09/2020
2CytokinesIBA
11/2020 - 01/2019
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2020 - 03/2005
2Methotrexate (Mexate)FDA LinkGeneric
01/2020 - 07/2011
2Mechlorethamine (Nitrogen Mustard)FDA Link
06/2015 - 04/2013
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
05/2014 - 03/2014
2Bevacizumab (Avastin)FDA Link
04/2014 - 04/2012
2ParaffinIBA
02/2013 - 10/2012
2Formaldehyde (Formol)FDA Link
02/2013 - 10/2012
2Monoclonal AntibodiesIBA
05/2012 - 09/2006
2fludarabineIBA
07/2011 - 03/2005
2NF-kappa B (NF-kB)IBA
08/2008 - 05/2008
2Transcription Factors (Transcription Factor)IBA
08/2008 - 05/2008
1Glucose (Dextrose)FDA LinkGeneric
06/2022
1AmylasesFDA Link
12/2021
1Lipase (Acid Lipase)FDA Link
12/2021
1obinutuzumabIBA
12/2021
1Tyrosine Kinase InhibitorsIBA
12/2021
1Filgrastim (Neupogen)FDA Link
06/2021
1gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
01/2021
1EnzymesIBA
01/2021

Therapy/Procedure

47Therapeutics
12/2022 - 07/2005
20Drug Therapy (Chemotherapy)
12/2021 - 09/2006
5Radiotherapy
10/2020 - 02/2013
5Stem Cell Transplantation
01/2020 - 09/2006
5Induction Chemotherapy
01/2018 - 12/2008
3Radioimmunotherapy
06/2021 - 08/2014
3Salvage Therapy
01/2021 - 07/2011
3Immunotherapy
11/2020 - 09/2011
3Autologous Transplantation
01/2019 - 10/2005
2Precision Medicine
06/2021 - 01/2018
2Combination Drug Therapy (Combination Chemotherapy)
10/2016 - 06/2015
2Cell Transplantation
01/2016 - 07/2011